• Allen, M.J., Myer, B.J., Khokher, A.M., Rushton, N. & Cox, T.M. (1997) Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10. The Quality Journal of Medicine, 90, 1925.
  • Barak, V., Acker, M., Nisman, B., Kalickman, I., Abrahamov, A., Zimran, A. & Yatziv, S. (1999) Cytokines in Gaucher's disease. European Cytokine Network, 10, 205210.
  • Baskurt, O.K. & Mat, F. (2000) Importance of measurement temperature in detecting the alterations of red blood cell aggregation and deformability studied by ektacytometry: a study on experimental sepsis in rats. Clinical Hemorheology and Microcirculation, 23, 4349.
  • Bax, B.E., Richfield, L., Bain, M.D., Mehta, A.B., Chalmers, R.A. & Rampling, M.W. (2005) Haemorheology in Gaucher disease. European Journal of Haematology, 75, 252258.
  • Ben-Ami, R., Barshtein, G., Zeltser, D., Goldberg, Y., Shapira, I., Roth, A., Keren, G., Miller, H., Prochorov, V., Eldor, A., Berliner, S. & Yedgar, S. (2001) Parameters of red blood cell aggregation as correlates of the inflammatory state. American Journal of Physiology. Heart and Circulatory Physiology, 280, H1982H1988.
  • Ben-Ami, R., Sheinman, G., Yedgar, S., Eldor, A., Roth, A., Berliner, A.S. & Barshtein, G. (2002) Thrombolytic therapy reduces red blood cell aggregation in plasma without affecting intrinsic aggregability. Thrombosis Research, 105, 487492.
  • Beutler, E. (2001) Discrepancies between genotype and phenotype in hematology: an important frontier. Blood, 98, 25972602.
  • Cabrera-Salazar, M.A., O'Rourke, E., Henderson, N., Wessel, H. & Barranger, J.A. (2004) Correlation of surrogate markers of Gaucher disease. Implications for long-term follow up of enzyme replacement therapy. Clinica Chimica Acta, 344, 101107.
  • Chen, S., Barshtein, G., Gavish, B., Mahler, Y. & Yedgar, S. (1994) Monitoring of red blood cell aggregability in a flow-chamber by computerized image analysis. Clinical Hemorheology, 14, 497508.
  • Chen, S., Gavish, B., Zhang, S., Mahler, Y. & Yedgar, S. (1995) Monitoring of erythrocyte aggregate morphology under flow by computerized image analysis. Biorheology, 32, 487496.
  • Grabowski, G.A. & Horowitz, M. (1997) Gaucher's disease: molecular, genetic and enzymological aspects. Baillieres Clinical Haematology, 10, 635656.
  • Hollak, C.E., Van Weely, S., Van Oers, M.H. & Aerts, J.M. (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. Journal of Clinical Investigation, 93, 12881292.
  • International Committee for Standardization in Haematology (1977) Recommendation of measurement of erythrocyte sedimentation rate of human blood. American Journal of Clinical Pathology, 68, 505507.
  • Nilsson, O., Hakansson, G., Dreborg, S., Groth, C.G. & Svennerholm, L. (1982) Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III. Clinical Genetics, 22, 274279.
  • Rogowski, O., Shapira, I., Zimran, A., Zeltser, D., Elstein, D., Attias, D., Bashkin, A. & Berliner, S. (2005) Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model. Blood Cells, Molecules, and Diseases, 34, 2629.
  • Suzuki, Y., Tateishi, N., Cicha, I. & Maeda, N. (2001) Aggregation and sedimentation of mixtures of erythrocytes with different properties. Clinical Hemorheology and Microcirculation, 25, 105117.
  • Whitfield, P.D., Nelson, P., Sharp, P.C., Bindloss, C.A., Dean, C., Ravenscroft, E.M., Fong, B.A., Fietz, M.J., Hopwood, J.J. & Meikle, P.J. (2002) Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: implications for the prediction of disease severity. Molecular Genetics and Metabolism, 75, 4655.
  • Zimran, A., Sorge, J., Gross, E., Kubitz, M., West, C. & Beutler, E. (1989) Prediction of severity of Gaucher's disease by identification of mutations at DNA level. Lancet, 2, 349352.